ArticleMolecular cancer therapeutics2023

MTX-13, a Novel PTK7-Directed Antibody-Drug Conjugate with Widened Therapeutic Index Shows Sustained Tumor Regressions for a Broader Spectrum of PTK7-Positive Tumors.

Chao Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.